[cancerpage is a service of Alere]
 


[home]
[search the site]
[my cancerpage]
[ribbon project]
[stories and experiences]
[glossary of terms]
[journal of hope]
[comments]
[about us]
[policies and disclaimers]
[physician and service directories]

Osteoporosis Common in Post-Gastrectomy Patients

NEW YORK FEB 01, 2008 (Reuters Health) - A new study confirms a high prevalence of osteoporosis and vertebral bone deformity in post-gastrectomy patients, regardless of the type of reconstruction procedure performed and the time elapsed since the operation.

Dr. Jong-Inn Lee and colleagues from the Korea Cancer Center Hospital in Seoul examined bone mineral density in 133 gastric adenocarcinoma patients who underwent curative surgery. The overall prevalence of osteoporosis in patients older than 50 years was 39.6%, they report in the December 28 issue of the World Journal of Gastroenterology.

The prevalence of osteoporosis in the lumbar spine was 29.8% in men and 54.4% in women. The prevalence of osteoporosis in the femoral neck was 11.9% in men and 26.3% in women. The overall rate of vertebral deformity was 46.6% -- 43.4% in men and 52.0% in women.

BMD and osteoporosis rates did not differ between patients with early or advanced gastric cancer. In addition, there was no difference in BMD or osteoporosis rates among patients who had Billroth I, Billroth II or Roux-en-Y reconstruction.

"These results indicate that gastrectomy itself affects BMD rather than the reconstruction method," Dr. Lee and colleagues write. "The osteoporosis rate in gastrectomy patients cannot be predicted by reconstruction type."

In multivariate analysis, anemia and age older than 64 were independent predictive factors for osteoporosis in men, with odds ratios of 4.8 and 3.9, respectively. In women, back pain was an independent risk factor for osteoporosis (odds ratio, 10.2).

"Considering the fact that gastric cancer patients after gastrectomy have many risk factors for osteoporosis fracture, early diagnosis and treatment are necessary," Dr. Lee and colleagues conclude. "Although some early results suggest that post-gastrectomy osteoporosis is resistant to treatment, effective results have recently been reported with the development of many anti-osteoporosis drugs."

SOURCE:

  • World J Gastroenterol 2007;13:6492-6497.



  • "Reuters content is the intellectual property of Reuters Limited. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon."
     

     MedlinePlus is a resource for health information offered to the public by the US Government. The search box below will direct you to publicly available health information from the National Institutes of Health, the FDA and other government agencies.
    Search MEDLINEplus:
     

    MEDLINEplus en español

     
    We subscribe to the HONcode principles of the Health On the Net Foundation


    cancerpage.com 2000
    - 2009 . Please send your feedback, comments and suggestions to our staff. Read our policies and terms of service . cancerpage.com is a service of Alere® .
    © (2009) Inverness Medical. All Rights Reserved. Alere is a trademark of the Inverness Medical group of companies.